Soligenix, Inc. (LON:0A6I)
1.822
0.00 (0.00%)
At close: Jun 13, 2025
Soligenix Revenue
Soligenix had revenue of $2.34K USD in the twelve months ending March 31, 2025, down -99.67% year-over-year. In the year 2024, Soligenix had annual revenue of $119.37K, down -85.78%.
Revenue (ttm)
$2.34K
Revenue Growth
-99.67%
P/S Ratio
1,721.60
Revenue / Employee
$146.38
Employees
16
Market Cap
3.12M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 119.37K | -719.99K | -85.78% |
Dec 31, 2023 | 839.36K | -109.55K | -11.55% |
Dec 31, 2022 | 948.91K | 124.64K | 15.12% |
Dec 31, 2021 | 824.27K | -1.54M | -65.07% |
Dec 31, 2020 | 2.36M | -2.27M | -49.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
Shell | 217.54B |
HSBC Holdings | 44.89B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
Soligenix News
- 24 days ago - Soligenix Highlights Dr. Ellen Kim's Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials - GlobeNewsWire
- 7 weeks ago - Soligenix GAAP EPS of -$1.06 misses by $0.39 - Seeking Alpha
- 7 weeks ago - Soligenix Announces Recent Accomplishments And First Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks - Benzinga
- 2 months ago - Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks - PRNewsWire
- 3 months ago - IBN Initiates Coverage of Soligenix Inc. - GlobeNewsWire
- 3 months ago - Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants - PRNewsWire
- 3 months ago - Soligenix GAAP EPS of -$4.98 - Seeking Alpha